Integra LifeSciences Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Integra LifeSciences (IART) Tops Q2 EPS by 23c
August 10, 2020 4:22 PM EDTIntegra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.33, $0.23 better than the analyst estimate of $0.10. Revenue for the quarter came in at $258.7 million versus the consensus estimate of $242.8 million.
The Company's full-year 2020 guidance remains withdrawn due to the uncertainty related to COVID-19 and... More
